---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-024492"
form_type: "8-K"
ticker: "WAT"
cik: "0001000697"
company_name: "WATERS CORP /DE/"
filed_at: "2026-01-27T23:59:59+00:00"
generated_at: "2026-05-16T07:20:02.993868+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Waters shareholders approve BD Biosciences combination; close expected Feb 9, 2026

## Summary
- Approximately 99% of shares present at special meeting voted to approve share issuance for BD Biosciences deal.
- Transaction expected to close on February 9, 2026, subject to remaining customary conditions.
- IRS private letter ruling on tax consequences received; all required regulatory approvals secured.
- Waters Q4 2025 earnings release and conference call rescheduled to February 9, 2026, in conjunction with close.

## SEC filing metadata
- accession: 0001193125-26-024492
- form_type: 8-K
- ticker: WAT
- cik: 0001000697
- company_name: WATERS CORP /DE/
- filed_at: 2026-01-27T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.07, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1000697/000119312526024492/0001193125-26-024492-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1000697/000119312526024492/d60099d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-024492
- JSON: https://secwatch.observer/filing/0001193125-26-024492.json
- Plain text: https://secwatch.observer/filing/0001193125-26-024492.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.